-
Should You Use a GLP-1 Medication to Lose the Last 5 to 10 Pounds?
GLP-1 medications like Wegovy, Zepbound, and compounded alternatives are increasingly being used to lose the “last 5 to 10 pounds.” But is that goal worth the long-term commitment these medications often require? As a registered dietitian and nutrition expert, I’ve been having more conversations about the tradeoffs, sustainability, and expectations surrounding weight loss medications. In this article, I explore the question I keep coming back to with clients: not whether these medications work, but what we’re truly hoping to gain from using them.
-
The End of Prediabetes? Understanding the Proposed Stages of Type 2 Diabetes
For decades, the term prediabetes has been used to describe blood glucose levels that are elevated above normal, but not yet high enough to meet the criteria for type 2 diabetes. However, a growing group of international diabetes experts is now questioning whether the term itself may contribute to clinical inertia and delayed treatment. In a recent commentary published in The Lancet Diabetes & Endocrinology, diabetes researchers proposed replacing the term prediabetes with a formal three-stage classification system. The goal is to better reflect the progressive nature of diabetes and encourage earlier intervention to reduce long-term complications. So what could…
